Register now!

Policies on in silico medicine are in their infancy. The Avicenna Alliance views early cooperation and harmonization of policies across borders to be of key importance to enabling the in silico market.

Too many policies have been developed across continents without any consultation with 3rd countries, the result being vastly differing Regulatory systems that pose obstacles for market development and unnecessary costs for all.

In order to avoid the need for retrospective harmonization, the Avicenna Alliance Working EU/US/Asia-Pacific Working Group will engage with colleagues and organisations in our field to ensure we achieve harmonization from the very beginning.

Avicenna Alliance news

Avicenna Alliance’s Secretary General to give keynote speech at ICCAI 2017

On 27-29 July 2017, the Society for Complex Acute Illness (SCAI) will organise the 16th annual International Conference on...

find out more ›

Avicenna Alliance represented at eHealth week in Malta!

The Avicenna Alliance has been invited to participate in a session dedicated to in silico trials on 12 May 2017 during the eHealth week in...

find out more ›

Avicenna Alliance invited to Joint Research Centre (JRC) Round Table Meeting in Ispra

The Joint Research Centre (JRC) located in Ispra, Italy organised a Round table meeting on 7 March 2017 to...

find out more ›

Show all activites